Damae Medical

DAMAE Medical operates in the healthcare and medical technology market, targeting dermatologists, hospitals, and research institutions. Their clients are primarily medical professionals who require precise and reliable tools for diagnosing skin conditions. The company’s technology allows for 3D segmentation of the skin surface and detailed analysis of skin layers, which helps in identifying cancerous cells without the need for invasive biopsies.

The business model of DAMAE Medical revolves around the development, production, and sale of their LC OCT devices. They generate revenue through the direct sale of these devices to hospitals and clinics, as well as through partnerships with research institutions. Additionally, they may offer maintenance and support services for their equipment, providing a recurring revenue stream.

DAMAE Medical has received significant financial backing, including millions in funding from the European Horizon 2020 program, which supports innovative projects in Europe. This funding has enabled them to advance their technology and expand their market presence. The company has also been recognized for its innovation, winning the World Competition of Innovation organized by Bpifrance in 2018.

In summary, DAMAE Medical is at the forefront of medical imaging technology, providing essential tools for the early detection of skin cancer. Their innovative approach and strong financial backing position them well in the healthcare market.